Health care system
-
2014 ATA Therapy guidelines: 3. Desiccated thyroid
This post continues my paraphrase of Jonklaas et al’s 2014 “Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement.” Posts in this series: 2014 ATA Thyroid therapy guidelines: 1. Levothyroxine 2014 ATA Thyroid therapy guidelines: 2. Ethics 2014 ATA Therapy guidelines: 3. Desiccated thyroid [this post]…
-
2014 ATA Thyroid therapy guidelines: 2. Ethics
Here I move on to part 2 of my summary of ATA thyroid therapy guidelines. Posts in this series: 2014 ATA Thyroid therapy guidelines: 1. Levothyroxine 2014 ATA Thyroid therapy guidelines: 2. Ethics [this post] 2014 ATA Therapy guidelines: 3. Desiccated thyroid 2014 ATA Therapy guidelines: 4. Using Synthetic T3 2014 ATA therapy guidelines: 5.…
-
2014 ATA thyroid therapy guidelines: 1. Levothyroxine
In this series of posts, I paraphrase a 2014 thyroid therapy guidelines document in a way that even the brain-fogged hypothyroid patient can understand more quickly and easily than reading the original version. Posts in this series: 2014 ATA Thyroid therapy guidelines: 1. Levothyroxine [this post] 2014 ATA Thyroid therapy guidelines: 2. Ethics 2014 ATA…
-
Pharma prejudice refuses a paradigm shift in thyroid therapy
This post engages in a moral argument, not a scientific one. Thyroid pharmaceutical prejudice is part of a paradigm that is refusing to shift. We need to keep asking key questions and fight together for this shift. Look around you today. Thyroid guidelines and health care systems currently treat all thyroid patients as one undifferentiated…
-
Pharmaceutical prejudice can lead to a thyroid therapy dystopia
I really DON’T want to be gloomy all the time. I DO believe there is hope for positive change in thyroid therapy today. But now and then we have to consider “what is the worst that could happen?” I want to show you where we are now, where we could all be headed if we…